Garrett Edmunds
Licensing Manager
Health Sciences
GarrettE@tla.arizona.edu
520-621-5511
Oncology - Therapeutics
- UA21-228 Discovery of an eIF4A Inhibitor with a Novel Mechanism of Action
- UA20-161 Design and Development of Innovative Formulations of Resatorvid for Targeted Skin Drug Delivery
- UA20-071 Sphyingolipid-Derived Cancer Nanotherapeutics
- UA19-063 Novel Compounds that Selectively Inhibit HSP70 Isoforms for the Treatment of Cancer
- UA19-015 G-Quadruplex Targeting Small Molecules for the Treatment of Castration Resistant Prostate Cancer and HSV-1
- UA14-091 Novel Inhibitors of the Androgen Receptor for the Treatment of Castration Resistant Prostate Cancer (CRPC)
- UA12-119 Design and Synthesis of a New Class of G-Quadruplex-Binding Ligands for the Treatment of Cancer and Other Diseases
- UA09-072 Design and Synthesis of a New Class of G-Quadruplex Binding Ligands for the Treatment of Cancer
- UA06-073 Combination Treatment for Cancer Involving CX-3543 and a PARP Inhibitor
Respiratory/Pulmonary/Vascular Diseases - Therapeutics
- UA22-008 Inhibition of SGK1 via a Synthetic Protein-Protein Interaction Inhibitory Peptide
- UA19-157 A New Method for Preventing and/or Treating Asthma and Related Respiratory Conditions
- UA18-048 Advanced Engineered Formulations Of Rho/Rock Kinase Inhibitor (fasudil) Microparticle/Nanoparticle Formulations For Inhalation Drug Delivery For Respiratory And Pulmonary Vascular Diseases And Applications Therein
- UA18-036 Advanced Engineered Formulations of Simvastatin and L-carnitine Microparticle/Nanoparticle Formulations for Inhalation Drug Delivery for Respiratory and Pulmonary Vascular Diseases and Applications Therein
- UA18-035 Proteins From Asthma-Protective Amish Farm Dust
- UA18-034 Advanced Engineered Formulations of TMP/Ligustrazine and Microparticle/Nanoparticle Formulations for Inhalation Drug Delivery for Lung Vascular, Interstitial and Airway Diseases
- UA16-075 Natural Treatment for Ventilation Induced Lung Injury
Viral - Therapeutics
- UA22-249 Allosteric Inhibitors of the Main Protease of SARS-CoV-2
- UA21-195 Novel Main Protease Inhibitors as SARS-CoV-2 Antivirals
- UA21-158 Discovery of Pyrazolopyridine Analogs as Broad-Spectrum Antivirals against Non-Polio Enteroviruses including EV-D68, EVA71, and CVB3
- UA21-133 PLpro Inhibitors Against SARS-CoV-2
- UA21-099 Discovery of Non-Covalent Inhibitors Targeting the SARS-CoV-2 Main Protease
- UA21-020 Repurposing of a Known Drug for Treatment of the Novel Coronavirus SARS-CoV-2 (COVID-19)
- UA20-216 Treatment of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) with a Polypeptide
- UA20-172 Bioactive Compounds for Use in Inhibiting SARS-CoV-2 Viral Replication
- UA19-186 Broad-Spectrum Antivirals Against Enterovirus D68, A71, and Coxsackievirus B3
Other - Therapeutics
- UA22-202 Method and System for Passive and Active Agent Delivery for Biomarker and Treatment Means
- UA21-128 Therapeutic Nanoparticles for Renal Disease
- UA20-171 T-Type Calcium Channel Enhancer for TAF1 Associated Neurological Defects
- UA20-128 Targeting 2AG Degradation for Headache
- UA20-108 Synthesis and Characterization of Innovative Formulations of Suramin Hydrogels for Drug Delivery and Applications Therein
- UA18-037 Advanced Engineered Formulations of Suramin Microparticles and Nanoparticles for Drug Delivery and Applications Therein
- UA18-028 Discovery of T-Type Calcium Channel Antagonist from Multicomponent Reactions and their Application in Paclitaxel-Induced Peripheral Neuropathy
Diagnostics/Biomarkers
- UA22-060 Variance of Fixed Joint Space Width and Nomogram to Predict Knee Replacement using Measures from Fixed Flexion Knee X-rays
- UA21-044 Non-Invasive Monitoring of the Autonomic Nervous System for Real-Time Assessment of Human Stress
- UA19-033 Diagnostic Analyte to Enrich LINE-1 and Detect LINE-1 Driven Oncologic Disease
- UA19-019 Biomarker For Heart Failure And Other Related Diseases
- UA19-018 Measuring Edema And Body Composition In Heart Failure Using NMR-MRI
- UA18-113 Drug Metabolite As A Non-Invasive Biomarker For Nonalcoholic Steatohepatitis (NASH)
- UA18-084 Biomarker to Assess Risk For Skin Cancer Development
- UA16-096 Novel Biomarker for Diagnosis and Treatment of Chronic Lung Diseases
- UA16-068 Reactive Oxygen Species Gene Signature Predicts Survival in Sepsis
- UA16-066 A Diagnostic Test for Schizophrenia
- UA14-146 Sweat Biomarkers as an Indication of Physiological Conditions
Animal Models
- UA21-039 Cyp2f2 Knock-Out Mouse
- UA20-038 GL261-luc2 Model
- UA20-171 T-Type Calcium Channel Enhancer for TAF1 Associated Neurological Defects
- UA19-203 Novel Knockout Model of ER-Beta in Rat Neurons
- UA19-202 Novel Knockout Model of ER-Alpha in Rat Neurons
- UA19-201 Novel Forebrain Neuron Specific CreERT2 Rat Model
- UA19-200 Novel Conditional Knockout Model of ER-Beta in Rats
- UA19-199 Novel Conditional Knockout Model of ER-Alpha in Rats
- UA19-004 Genetic Rat Model For Pulmonary Hypertension
- UA09-110 Mouse Model of Human Asthma and Allergy
Research Tools
- UA22-051 Tunable Fluorescent Indolizine Tetracycles
- UA21-223 Apparatus for Active Tissue Scaffold Stretching in Cell Culture Conditions
- UA20-226 Serological Assays for SARS-CoV-2
- UA19-149 Methods and Apparatus Suitable for Interrogating Biological Systems: Tumor-on-Chip
- UA19-144 Methods for Building a Self-Contained Responsive Biological System
- UA17-163 Pellet Dispenser for Small Laboratory Animal Cages
- UA17-076 Apparatus for Reconfiguration of Components in a Micro-Physiological System
- UA16-224 Pharmacogenomics of Intergenic SNPs and in Silico Modeling for Precision Therapy
- UA16-150 Disposable Partial Vertebrate Animal Cage Divider
- UA14-088 Method for Guiding Cell Spreading in Automated Cytogenetics Assays
Medical Devices
- UA20-222 Precision Brachytherapy Device for Esophageal Cancer
- UA20-177 Safe Specimen Transportation Isolation Container (STIC)
- UA20-024 Bed-Sled 2
- UA19-180 Baro-Balloon
- UA19-091 An Implantable Miniaturized and Soft Wireless Sensor to Monitor Tissue and Bone Deformation
- UA18-124 Integrated Device for Self-Collecting and Automated Pre-Processing of Biological Fluids for Multiple Analyses
- UA16-025 Systems, Methods, Devices and Material for Definition, Monitoring and Modulation of Organism Flexibility
- UA16-024 Systems, Methods, Devices and Material for Definition, Monitoring and Modulation of Organism Strength
- UA15-179 Method for Determining Cell Stiffness
- UA15-157 Dyzo-Piezo Electric System for Measuring Tissue Properties
- UA15-141 Real-Time Reflex Pupillometry Device for Neuro-Physiologic Monitoring
- UA15-035 HyperShear in a Channel: a Microfluidic Facsimile of Ventricular Assist Devices to Reduce Thrombotic Risk and Enhance Patient Safety
- UA14-085 Modulation of Platelet Function
- UA14-076 Piezo Electric Energy Harvesting System
- UA13-122 New Device for Electropolmeric Paving and Sealing
Imaging
- UA20-239 Imaging Human Respiratory Gas Patterns, Volume, Rate and Carbon Dioxide
- UA15-176 Image-Guided Microwave Therapy
- UA12-086 Formulaic Imaging for Tissue Diagnosis
FemTech
- UA24-108 Metabolic Screening Methods for Endometrial Cancer
- UA23-227 Phenyllactic Acid: Antimicrobial Activity against Vaginal Microbiota and Cytotoxic Properties on Human Cervical Epithelial Cells
- UA23-186 Methods for Guiding Treatments of Vulvovaginal Symptoms and Female Sexual Dysfunction
- UA22-282 A Steerable, Optically Guided System for Detection of Ureteral Injury and Ureteral Catheterization
- UA22-220 Diagnostic for Non-Invasive Screening and Early Detection of Adenomyosis
- UA22-024 Diagnostic for Screening and/or Predicting Women "at risk" for the Development and Progression Endometrial Cancer
- UA20-019 Diagnostic for Monitoring Response to Immunotherapies for Gynecologic Cancer
- UA19-280 Cell Collection Device for Biological Analysis
- UA19-279 Mode Scrambler for Increasing Numerical Aperture
- UA19-249 3D Printed Lens for Imaging in Falloposcope
- UA15-030 Optical Imaging Falloposcope for Minimally Invasive Ovarian Cancer Detection
Mouse Models for Nervedegenerative Disease Research
- UA24-233 Novel Mouse Strain for Inflammation and Neurodegeneration
- UA24-234 Novel, Humanized Transgenic Background Mouse Strain for Neurodegenerative Disease Research
Other
- UA20-253 Visible-Light Mediated Organophotoredox Catalytic Deuteration of Aromatic and Aliphatic Aldehydes
- UA20-052 Methods for Practical Synthesis of Deuterated Amino Acids
- UA20-037 Methods for Practical Synthesis of Deuterated Aldehydes
- UA19-045 Smart Box for Health Logistics
- UA18-174 Method and System for Biological Information Pattern Storage and Readout